I would like to express my warmest thanks for your continued support.
In the four years since 2012 when I assumed the position of President, Olympus has been focusing on both restoring trust in the company, and on rebuilding our management structure. As a result, we are now past that previous difficult period in our company's history, and our management is now concentrating not on rebuilding, but on future growth. To this end, we have formulated "16CSP" - our new five-year medium-term management plan, which is propelling us on our way towards sustainable growth into the future.
In 2019, during the period of the 16CSP medium-term plan, Olympus will commemorate the 100th anniversary of its establishment. As we pass this milestone, we have positioned 16CSP to create both the strong foundations and the assertive business portfolio required to achieve enduring growth for the next 100 years. To this end, it is necessary to accelerate growth in our key business of medical field, and thereby become a world-class player in the near future.
We will further prioritize investment in managerial resources for our medical business, and work to both expand our range of business, and enhance profitability. Also of importance are the construction of a solid financial foundation becoming a global medical device manufacturer, as well as enhanced compliance. By using these initiatives to maximize corporate value and targeting a total shareholder return ratio of 30%, we hope to meet the expectations of our shareholders.
In line with our corporate philosophy of "Making people's lives healthier, safer and more fulfilling," Olympus will continue to develop and grow together with society. We look forward to your continued understanding and support.